Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by funky99

ATBPF

RE:RE:RE:Clinical Development

Revenue TTM is $7.1 millions. Information is available with my broker TD and...

September 15, 2016

ATBPF

9th International Symposium on Cell/Tissue Injury

John Wallace on the Scientific Advisory Board September 15-17th 2016 9th...

September 12, 2016

ATBPF

RE:RE:Share Ownership

51.2% of O/S is held by insider (13 holders)

September 8, 2016

ATBPF

Antibe Therapeutics to Present at 2016 Rodman & Renshaw Glob

http://finance.yahoo.com/news/antibe-therapeutics-present-2016-rodman...

September 6, 2016

ATBPF

RE:RE:As a Long, What Discourages Me?

I personnally think the Biotech sector in Canada has suffered for a while...

September 1, 2016

ATBPF

Antibe Therapeutics Podcast Biotechnology Focus

ProMetic Life Science hits two significant clinical milestones, Antibe...

August 26, 2016

ATBPF

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Execution

Knight Therapeutics secured territory rights for the below region in exchange...

August 25, 2016

ATBPF

RE:RE:RE:RE:RE:RE:Execution

Per MD&A and investors presentation they are talking about Q2 2017 for...

August 21, 2016

ATBPF

Antibe Therapeutics Announces the Launch of Neomem

http://www.businesswire.com/news/home/20160816005426/en/

August 16, 2016

ATBPF

Knight Lends a Second Hand to Bloom Burton Debt Fund

Interesting news today. The Bloom Burton fund already invested in Antibe...

August 12, 2016

V.RX

BioSyent Releases Q2 and H1 2016 Results

Available in a pdf format on Biosyent website. https://docs.google.com/viewer...

August 12, 2016

ATBPF

RE:RE:RE:RE:This is really bullish news

I would suggest you read Knight Therapeutics investor presentation to see how...

August 8, 2016

ATBPF

RE:RE:This is really bullish news

Serious partnership? They already did.....Knight Therapeutics GUD.TO and...

August 8, 2016

ATBPF

Successful Phase 2 Trial of ATB-346 in Osteoarthritis

Long! http://www.stockhouse.com/news/press-releases/2016/08/08/antibe...

August 8, 2016

T.MDP

RE:RE:Another 2 Big Approvals coming this November & 2Q = 1000%

Congrats to the long. Pediapharm is starting to unfold with good news slowly....

July 21, 2016

ATBPF

Update on Phase 2 Trial of ATB-346

http://www.businesswire.com/news/home/20160719005523/en/Antibe-Therapeutics...

July 19, 2016

ATBPF

RE:results...

tick tick tick....waiting....being patient...

July 18, 2016

ATBPF

Private placement insiders

Interesting to see Chair of the Board, VP Business Development and Chief...

July 14, 2016

ATBPF

RE:300,000 shares RH to LH

This is probably a cross trade from one account to another one from the same...

July 8, 2016

T.PRN

RE:RE:RE:Jonathan Goodman

Also check Antibe Therapeutics ATE.V for which Jonathan Goodman was on the...

July 7, 2016

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Next

Featured Company

Innocan Pharma Corp

Innocan Pharma Corp C.INNO

Innocan Pharma Corporation is an Israel-based company active in the pharmaceuticals and wellness sectors. In the ... view more »